Vein Graft Disease
Therapy facilitates better repair following coronary treatment
Published in Gene Therapy Weekly, May 9th, 2002
Vein graft disease is characterized by neointimal thickening and the risk for thrombosis in the grafted vein. Vascular smooth muscle cells are the major constituents of neointimal hyperplasia, making them suitable targets for strategies designed to control proliferation following surgery. Because CNP inhibits vascular smooth muscle cells, investigators at Kyoto University Graduate School of Medicine in Japan believe it could be used in gene therapy to prevent vein graft disease while at...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2002-05-09)
More Articles from Gene Therapy Weekly
- Neuropathy
Advances allow astrocytes to serve as transfer stations in the CNS - Reconstructive Surgery
Genetically modified cells reinforce flap healing in rodents - Gene Triggering
Inducible construct overrides cellular attempts at survival - Glioblastoma
Highly vascular brain tumors react to adrenomedullin inhibition - Transfusion Therapy
Antiapoptosis gene could extend cell survival in cancer therapies - Drug Discovery
Transfac subscriptions renewed by Merck & Co. and Schering-Plough Research Institute - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
